Carlson Capital, L.P. / ARRYEUR
Carlson Capital, L.P.’s Array Biopharma Inc Position
Does Carlson Capital, L.P. own Array Biopharma Inc (ARRYEUR)? Not currently — the last reported position was 947.2K shares worth $44M in Q2 2019; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$44M
Q2 2019
Shares
947.2K
% of Portfolio
+0.66%
Quarters Held
1
position exited
Position History ARRYEUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2019 | 947.2K | $44M | +0.66% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Carlson Capital, L.P.’s full portfolio or all institutional holders of ARRYEUR.